[SLRX] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
01-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -10.08%
YoY- -2.81%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 105 163 251 246 179 283 414 -59.96%
PBT -2,230 -2,009 -2,638 -9,052 -8,223 -8,029 -9,332 -61.52%
Tax 0 -51 0 0 0 -74 0 -
NP -2,230 -2,009 -2,638 -9,052 -8,223 -8,029 -9,332 -61.52%
Tax Rate - - - - - - - -
Total Cost 2,335 2,172 2,889 9,297 8,402 8,312 9,746 -61.45%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -2,124.68 -1,232.52 -1,051.18 -3,687.09 -4,604.73 -2,837.10 -2,256.31 -3.93%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -77.16 -69.50 -91.27 -313.66 -287.22 -284.43 -335.48 -62.49%
EPS Diluted -77.16 -69.50 -91.27 -313.66 -287.22 -284.43 -335.48 -62.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.